Loading…
Data as of .
| Company | Industry | Market cap | 1M | 6M | Revenue growth | Op. margin | Fwd P/E |
|---|---|---|---|---|---|---|---|
| Merck KGaA MRK.DE | Pharmaceuticals: Major | $72.5B | +10% | +23% | 0% | 20% | 17.5× |
| Bayer BAYN.DE | Pharmaceuticals: Major | $61.2B | +30% | +46% | -2% | 14% | 12.3× |
| Siemens Healthineers SHL.DE | Medical Specialties | $55.9B | +17% | +31% | -1% | 15% | 18.9× |
| Fresenius SE & Co. KGaA FRE.DE | Hospital/Nursing Management | $32.8B | +26% | +34% | +6% | 10% | 14.5× |
| Sartorius SRT.DE | Medical Specialties | $20.0B | +16% | +34% | +4% | 18% | 42.6× |
| Fresenius Medical Care FME.DE | Medical/Nursing Services | $12.6B | +15% | +14% | 0% | 11% | 10.4× |
| Fielmann FIE.DE | Medical Specialties | $4.12B | +18% | +3% | +3% | 14% | 17.8× |
| SCHOTT Pharma AG & Co. KGaA 1SXP.DE | Medical Specialties | $3.67B | -12% | +31% | +4% | 15% | 22.1× |
| Carl Zeiss Meditec AFX.DE | Medical Specialties | $3.51B | +13% | +40% | 0% | 8% | 26.8× |
| Ottobock SE & Co. KGaA OBCK.DE | Medical Specialties | $3.36B | -10% | -25% | +5% | 15% | 15.4× |
| Dermapharm DMP.DE | Pharmaceuticals: Major | $2.11B | 0% | -25% | 0% | 22% | 14.5× |
| Draegerwerk AG & Co. KGaA DRW8.DE | Medical Specialties | $1.89B | -11% | +17% | +5% | 7% | 9.4× |
| Redcare Pharmacy RDC.DE | Medical Distributors | $1.63B | -3% | +52% | +19% | 0% | n/a |
| Rhon-klinikum RHK.DE | Hospital/Nursing Management | $1.08B | 0% | +14% | +5% | 3% | 22.5× |
| Eckert & Ziegler EUZ.DE | Medical Specialties | $969M | +13% | -7% | +4% | 25% | 17.0× |
| Evotec EVT.DE | Miscellaneous Commercial Services | $630M | +13% | -33% | -8% | -19% | n/a |
| M1 Kliniken M12.DE | Medical/Nursing Services | $376M | -5% | +3% | -28% | 13% | 18.5× |
| Stratec SBS.DE | Medical Specialties | $341M | +14% | +41% | -3% | 3% | 16.4× |
| Medios ILM1.DE | Medical Distributors | $324M | +11% | -9% | +10% | 2% | 9.8× |
| MEDICLIN Aktiengesellschaft MED.DE | Hospital/Nursing Management | $285M | +6% | +48% | +3% | 8% | 6.8× |
| Formycon FYB.DE | Pharmaceuticals: Major | $280M | -27% | -26% | +18% | -26% | n/a |